« Back

Our Research
 

rheumatology research banner

  • Antiphospholipid Antibodies and Lupus: New Molecular Targets for Treatment, NIH-sponsored, 2013 - present
  • A Multicenter International Prospective, Randomized Controlled Trial of Hydroxychloroquine in the Primary Thrombosis Prophylaxis of Persistently Antiphospholipid Antibody (aPL) Positive but Thombosis-free Patients without Systemic Autoimmune Disease, 2013 - present
  • An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome, 2013 - present
  • A Phase IIb, Multi-Center, Randomized, Double-Blind,Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept (TACI-Ig) in Subjects With Systemic Lupus Erythematosus (SLE), 2014 - present.
  • "Treat-to-Target", a multi-center trial of RA, NIH-sponsored, out of Harvard university, Boston, under the leadership of Dr. Daniel Salomon, 2014 - present
  • Determination of cultured endothelial cells to examine the effects of various inhibitors that may block their binding and activation determine their thrombogenic effects in mice, 2007 - present
  • Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) International Clinical Database and Repository Collaborative Registry, 2013 - present

Elizabeth Papalardo Elizabeth Papalardo
Research Associate III
Division of Rheumatology
Department of Internal Medicine
elpapala@utmb.edu

Zurina Romay-Penabad Zurina Romay-Penabad, PhD
Post-Doctoral Fellow
Division of Rheumatology
Department of Internal Medicine
zuromayp@utmb.edu

Alvaro Schleh Alvaro Schleh
Coordinator
Division of Rheumatology
Department of Internal Medicine
alschleh@utmb.edu

Rohan Willis Rohan Willis
Research Fellow
Division of Rheumatology
Department of Internal Medicine
rowillis@utmb.edu

Site Managed by UTMB Information Design Services.